News from oramed pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 22, 2013, 16:30 ET

Oramed Pharmaceuticals Announces Reverse Stock Split

Oramed Pharmaceuticals Inc. (OTCQB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its previously...

Jan 07, 2013, 09:20 ET

Oramed Pharmaceuticals Files Investigational New Drug Application with the FDA for Oral Insulin

Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has filed...

Dec 11, 2012, 09:20 ET

Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has completed...

Nov 07, 2012, 09:20 ET

Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012

Oramed Pharmaceuticals Inc. (OTCBB: ORMP; www.oramed.com), a developer of oral delivery systems, announced today that results of a study performed...

Oct 18, 2012, 09:20 ET

Former Johnson & Johnson and Bausch & Lomb Executive, Gerald Ostrov, Joins Oramed Pharmaceuticals' Board of Directors

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that Gerald Ostrov,...

Oct 03, 2012, 09:20 ET

Oramed Pharmaceuticals to Collaborate With Leading Contract Research Organization Medpace for Phase II FDA Trial on Oral Insulin

Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its...

Jul 11, 2012, 09:20 ET

Oramed Pharmaceuticals Granted 2nd Patent in New Zealand; 3rd Patent for Core Technology on Oral Delivery of Proteins

Announcing its third patent approval since the beginning of the calendar year, Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (www . oramed . com), a...

Jun 04, 2012, 09:20 ET

Oramed Pharmaceuticals to Present at the 72nd Scientific Sessions of the American Diabetes Association in Philadelphia, PA, June 8-12, 2012

Oramed Pharmaceuticals (OTCBB: ORMP.OB), a developer of oral delivery systems, announced today that its abstract, "Concomitant oral...

May 29, 2012, 09:26 ET

Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...

May 21, 2012, 05:24 ET

Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of oral delivery systems, announced today that it was chosen to present at the...

Feb 07, 2012, 09:20 ET

Oramed Pharmaceuticals Announces Educational Lecture at the National University Hospital in Singapore

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that Dr Miriam Kidron,...

Jan 24, 2012, 09:20 ET

Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Company's Core Technology in Oral Delivery of Proteins

Marking a major milestone for the Company, Oramed Pharmaceuticals Inc. (OTCBB: ORMP) (http://www.oramed.com), a developer of oral drug delivery...

Jan 10, 2012, 09:15 ET

Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has filed a...

Oct 25, 2011, 09:20 ET

Oramed Pharmaceuticals Chosen to Present at the Diabetes Technology Meeting (October 27-29, 2011; San Francisco, CA)

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its work...

Sep 27, 2011, 08:25 ET

Oramed Pharmaceuticals Announces Successful Phase 1 Clinical Trial Results for EnteraBio

Oramed Pharmaceuticals Inc. (OTC BB: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced that EnteraBio Ltd. recently...

Sep 15, 2011, 09:20 ET

Oramed Pharmaceuticals Chosen to Present at the 8th Annual Israel Strategic Partner and Venture Conference on September 22, 2011

Oramed Pharmaceuticals Inc. (OTC BB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that Ehud Arbit,...

Sep 08, 2011, 09:20 ET

Oramed Pharmaceuticals to Present at Rodman & Renshaw 13th Annual Global Investment Conference

Oramed Pharmaceuticals Inc. (OTC BB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that Roy Eldor, M.D.,...

Jun 22, 2011, 09:20 ET

Oramed Pharmaceuticals Appoints Dr. Michael Berelowitz as Chairman of Scientific Advisory Board

  Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a biotech company with a novel platform technology for the oral delivery of drugs currently...

May 18, 2011, 09:20 ET

Oramed Pharmaceuticals to Present at The 1st Asia Pacific Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CHODy), China 2011

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that it was chosen to...

May 11, 2011, 09:30 ET

Oramed Pharmaceuticals to Present at the 10th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2011

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that it was chosen to...